glp-1 agonist or antagonist GIP-derived GIP receptor antagonists – a review of their role in GIP receptor pharmacology Central glucagon-like peptide 1 receptor

Injectable BPC-157 is recommended for injury recovery and systemic use

IOP Conference Series: Materials Science and Engineering, Volume 544, 2nd International Conference on Mechanical Engineering and Applied Composite Materials 78 December 2018 pp

Rusmini et al., 2020)

BPC 157 (10 g/kg, 10 ng/kg) is applied either intraperitoneally once time daily (first application immediately after surgery, last at 24 hours before sacrifice) or per-orally in drinking water (0.16 g/ml/12 ml/day till the sacrifice)

If results remain unexplained, particularly with very high levels, further investigation may include imaging or haematology referral depending on clinical context and associated abnormalities

Prevention of Bacterial Growth: Storing peptides in a refrigerator reduces the risk of bacterial contamination, which can occur at higher temperatures